AlphaLife Sciences has joined the NVIDIA Inception Program, enhancing our GenAI-powered platform, AuroraPrime. This strengthens our ability to deliver GenAI-copiloted medical writing solutions, improving efficiency and automating the clinical research process—from protocol design to CSR drafting—for pharmaceutical companies.
Aug 22, 2024 Read More
Our SVP Alice Hsu presented on AI-powered clinical trials at DIA 2024, showcasing AuroraPrime's transformative features. CEO Sharon Chen shared strategic insights as a panel expert, highlighting our innovative approaches.
Jul 18, 2024 Read More
At the SCDM China Conference 2024, Patrick Nadoiny, SCDM Chair and Global Head of Clinical Data Management at Sanofi, delivered an insightful presentation. Sharon Chen, our CEO, showcased innovative Gen-AI applications.
Jun 27, 2024 Read More
At the DIA Global Annual Meeting, AlphaLife Sciences showcased advanced generative AI solutions, revolutionizing clinical trials with unmatched efficiency and speed, transforming drug development.
Jun 21, 2024 Read More
AlphaLife Sciences is grateful to join JLABS and the Global Roadshow at the BIO International Convention. This experience highlighted JLABS' support, fostering connections, and accelerating medical innovation through AI-based clinical research solutions.
Jun 10, 2024 Read More
AlphaLife Sciences joins Johnson & Johnson Innovation ‒ JLABS in Singapore, highlighting its promise in leveraging AI to accelerate clinical development and advance the medical AI field.
May 25, 2024 Read More
AlphaLife Sciences CEO Sharon Chen joined the Microsoft Build: AI Day in Bangkok, engaging with top CEOs and Satya Nadella on advancing AI and cloud technology.
May 02, 2024 Read More
Dear partners, we sincerely thank you for your collaboration with Alphalife Sciences throughout 2023. During this year, we engaged in comprehensive collaborations with many multinational pharmaceutical corporations (MNCs), leading domestic pharmaceutical companies, biotech firms, and mainstream CROs across various therapeutic areas, both domestically and internationally. These partnerships were instrumental in driving innovation in the pharmaceutical field and showcased the continual growth and advancement of Alphalife Sciences. Your ongoing support has been a driving force in our progress. Let's revisit this year filled with achievements.
Jan 09, 2024 Read More
In the surge of generativeAI, global pharmaceutical companies are actively exploring how to leverage AI to accelerate medical innovation and clinical trial processes. In this CMAC Clinical Research Informatization Club event at GSK industry colleagues will delve into 'The Latest Developments in Large Language Models in China' and 'Exploration of AI Applications in Pharmaceutical and Vaccine Development in China'.Ms. Sharon Chen, CEO of Alphalife Sciences and Chairperson of the CMAC Clinical Research Informatization Club, is invited as an honorary guest to share her profound insights on how generativeAI can assist enterprises in transforming clinical informatization. Additionally, Bogong Zhu, Chief Product Officer of Alphalife Sciences and a seasoned AI product expert, is also invited to participate in this event on AI and Pharmaceutical Innovation. Let's explore the endless possibilities of AI together and move towards a smarter and more efficient new era of clinical research!
Nov 23, 2023 Read More
The 2023 AI in Pharma Annual Conference will be held from Wednesday, October 4th, to Thursday, October 5th, 2023, in Boston. AI in Pharma is dedicated to providing a global platform for the exchange of ideas and collaboration to drive innovation in science and medicine. This two-day conference will explore specific applications and key challenges of artificial intelligence in drug discovery and clinical trials.
Sep 27, 2023 Read More
